Floatz logo

S-1

Intestinal Neoplasms

Fudan UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Intestinal Neoplasms cohort.

Asset / SponsorPhaseRating
Irinotecan
Pfizer
Phase 3BB
FLUOROURACILUM
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3BB
Capecitabine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3BB
Calcium folinate pentahydrate
Fudan University
Phase 3BB
Eloxatin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3BB

View all 16 →

Same molecule, other indications

S-1 is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative ·
71 / 100
View asset →
Gastric NeoplasmDormant
BB
Indicative ·
69 / 100
View asset →
malignant pancreatic neoplasmDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →